from Reuters: Business News https://ift.tt/32UxrJU
Saturday, July 27, 2019
Home »
business news
,
latest business news
» Pfizer in talks to merge off-patent drugs business with Mylan
Pfizer in talks to merge off-patent drugs business with Mylan
Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.

from Reuters: Business News https://ift.tt/32UxrJU
from Reuters: Business News https://ift.tt/32UxrJU
Related Posts:
IKEA says Ingvar Kamprad, the IKEA founder who created a global furniture empire, has died at 91 IKEA says Ingvar Kamprad, the IKEA founder who created a global furniture empire, has died at 91 IKEA says Ingvar Kamprad, the IKEA founder who created a global furniture empire, has died at 91. … Read More
Manmade quakes force Dutch to face future without gas Manmade quakes force Dutch to face future without gas When Nienke Bastiaans fell in love with and bought a 17th-century thatched house in a rural Dutch village, there was one person who warned about possible earthquakes d… Read More
Freed Saudi prince's Kingdom Holding firm climbs 10 percent Freed Saudi prince's Kingdom Holding firm climbs 10 percent Stocks in Saudi Prince Alwaleed bin Talal's investment firm have surged a day after he was released from detention in connection with an anti-corruption campaign… Read More
IKEA says founder Ingvar Kamprad has died at 91 IKEA says founder Ingvar Kamprad has died at 91 IKEA says Ingvar Kamprad, the IKEA founder who turned a small-scale mail order business into a global furniture empire, has died at 91. IKEA Sverige, the chain's Swedish uni… Read More
At Davos, the Real Star May Have Been China, Not Trump By KEITH BRADSHER from NYT Business Day http://ift.tt/2nj0O5w … Read More
Watch: Key moments in Trump's 'Liberation Day' tariffs announcement
The US president said universal 10% tariffs would go into effect for all countries starting 5 April. from BBC News https://ift.tt/6RUSGjE ...
0 comments:
Post a Comment